Henlius Biotech H Shares Trading Halted
Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update.
Trading of Shanghai Henlius Biotech, Inc.’s H shares has been temporarily halted as of 9:00 a.m. on May 23, 2024, in anticipation of a forthcoming announcement related to the Code on Takeovers and Mergers. This action is expected to be significant, containing inside information that could impact the company’s stock performance. Investors are advised to stay tuned for updates that could influence their financial decisions.
For further insights into HK:2696 stock, check out TipRanks’ Stock Analysis page.
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.